Altered RNA turnover in carcinogenesis

[1]  Y. Li,et al.  Simultaneous determination of pseudouridine and creatinine in urine of normal children and patients with leukaemia by high performance liquid chromatography. , 1992, Biomedical chromatography : BMC.

[2]  S. Ishiwata,et al.  Relationship of urinary pseudouridine and 1-methyladenosine to activity of leukemia and lymphoma. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[3]  G. Björk,et al.  Excretion of pseudouridine as an independent prognostic factor in renal cell carcinoma. , 1991, Acta oncologica.

[4]  H. Topp,et al.  Chapter 13 Modified Nucleosides and Nucleobases in Urine and Serum as Selective Markers for The Whole-Body Turnover of tRNA, rRNA and mRNA-CAP - Future Prospects and Impact , 1990 .

[5]  J. Mackenzie,et al.  Chapter 11 RNA Catabolites in Health and Disease , 1990 .

[6]  K. Higashino,et al.  Serum pseudouridine as a biochemical marker in patients with hepatocellular carcinoma. , 1988, Clinica chimica acta; international journal of clinical chemistry.

[7]  P. Sharp,et al.  Splicing of messenger RNA precursors. , 1987, Science.

[8]  E. Cadman,et al.  Acute effect of 5-fluorouracil on cytoplasmic and nuclear dihydrofolate reductase messenger RNA metabolism. , 1986, The Journal of biological chemistry.

[9]  Y. Moriwaki,et al.  Urinary excretion of pseudouridine in patients with hepatocellular carcinoma , 1986, Cancer.

[10]  K. Higashino,et al.  Urinary pseudouridine as a tumor marker in patients with small cell lung cancer. , 1986, Clinica chimica acta; international journal of clinical chemistry.

[11]  C. Takimoto,et al.  Fluoropyrimidine-mediated changes in small nuclear RNA. , 1986, Journal of Biological Chemistry.

[12]  M. Grever,et al.  Urinary nucleosides in leukemia: laboratory and clinical applications. , 1986, Critical reviews in clinical laboratory sciences.

[13]  M. Cohen,et al.  Cytotoxicity and the inhibition of ribosomal RNA processing in human colon carcinoma cells. , 1985, Molecular pharmacology.

[14]  G. Nass.  Modified Nucleosides and Cancer , 2011, Recent Results in Cancer Research/Fortschritte der Krebsforschung/Progrès dans les recherches sur Ie cancer.

[15]  M. Grever,et al.  Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemia. , 1983, Journal of the National Cancer Institute.

[16]  I. Selikoff,et al.  Urinary excretion of modified nucleosides in patients with malignant mesothelioma. , 1983, Cancer research.

[17]  M. Grever,et al.  Urinary excretion of modified nucleosides in chronic myelogenous leukemia. , 1983, The Journal of laboratory and clinical medicine.

[18]  M. Grever,et al.  Differential excretion of modified nucleosides in adult acute leukemia. , 1983, Blood.

[19]  G. Björk,et al.  Tumor markers in bronchogenic carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine. , 1983, Acta radiologica. Oncology.

[20]  J. S. Harris,et al.  Specific effects of 5-fluoropyrimidines and 5-azapyrimidines on modification of the 5 position of pyrimidines, in particular the synthesis of 5-methyluracil and 5-methylcytosine in nucleic acids. , 1983, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[21]  J. Mackenzie,et al.  Comparison of urinary modified nucleosides and bases in rats with hepatomas and nephroblastomas. , 1983, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[22]  M. Slavik,et al.  Urine levels of N-[9-(beta-D-ribofuranosyl)purin-6-ylcarbamoyl]-L-threonine, N6-(delta 2-isopentenyl)adenosine, and 2'-O-methylguanosine as determined by radioimmunoassay for normal subjects and cancer patients. , 1982, Cancer research.

[23]  D. Ettinger,et al.  Biological markers and small cell carcinoma of the lung. A clinical evaluation of urinary ribonucleosides , 1982, Cancer.

[24]  M. Heddrich,et al.  Determination of RNA-metabolism as indicator of nutritional status. , 1982, Klinische Padiatrie.

[25]  C. Speicher,et al.  Elevated nucleoside excretion by patients with nasopharyngeal carcinoma: Preliminary diagnostic/prognostic evaluations , 1982, Cancer.

[26]  R. Pergolizzi,et al.  The effect of exogenous nutrients on the biosynthesis of Y base in tRNAPHe from Ehrlich ascites carcinoma. , 1980, Cancer letters.

[27]  K. Kuo,et al.  Patterns of urinary excretion of modified nucleosides. , 1979, Cancer research.

[28]  Y. Kuchino,et al.  Tumour-specific phenylalanine tRNA contains two supernumerary methylated bases , 1978, Nature.

[29]  S. Belman,et al.  High turnover rate of transfer RNA in tumor tissue. , 1977, Cancer research.

[30]  K. Randerath,et al.  Transfer RNA in hepatomas. , 1977, Advances in experimental medicine and biology.

[31]  J. Skoda,et al.  Increased Urinary Pseudouridine Excretion in Rats following Irradiation , 1964, Nature.